| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(R) | 774 | 96.1% | -7.27 | 5 | 1.2% |
| CA(R) | 20 | 2.5% | 4.33 | 403 | 97.1% |
| CentralBrain-unspecified | 8 | 1.0% | -1.00 | 4 | 1.0% |
| PED(R) | 3 | 0.4% | 0.00 | 3 | 0.7% |
| upstream partner | # | NT | conns VP3+_vPN | % In | CV |
|---|---|---|---|---|---|
| TRN_VP3b | 1 | ACh | 299 | 41.0% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 86 | 11.8% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 60 | 8.2% | 0.0 |
| VP3+_l2PN (R) | 3 | ACh | 52 | 7.1% | 0.6 |
| TRN_VP3a | 3 | ACh | 34 | 4.7% | 0.5 |
| lLN2R_a (R) | 2 | GABA | 21 | 2.9% | 0.5 |
| HRN_VP1l | 4 | ACh | 16 | 2.2% | 0.5 |
| v2LN49 (R) | 2 | Glu | 14 | 1.9% | 0.7 |
| lLN2F_a (R) | 2 | unc | 14 | 1.9% | 0.1 |
| l2LN20 (R) | 2 | GABA | 13 | 1.8% | 0.1 |
| HRN_VP4 | 2 | ACh | 11 | 1.5% | 0.5 |
| v2LN4 (L) | 2 | ACh | 10 | 1.4% | 0.2 |
| GNG121 (L) | 1 | GABA | 9 | 1.2% | 0.0 |
| lLN2X12 (R) | 3 | ACh | 9 | 1.2% | 0.0 |
| v2LN41 (R) | 1 | unc | 8 | 1.1% | 0.0 |
| LHAD4a1 (R) | 1 | Glu | 8 | 1.1% | 0.0 |
| CB1048 (R) | 1 | Glu | 7 | 1.0% | 0.0 |
| lLN2T_a (R) | 2 | ACh | 6 | 0.8% | 0.7 |
| lLN2X11 (R) | 2 | ACh | 6 | 0.8% | 0.3 |
| lLN2X04 (R) | 2 | ACh | 5 | 0.7% | 0.6 |
| lLN1_bc (R) | 3 | ACh | 4 | 0.5% | 0.4 |
| SLP184 (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| lLN2T_c (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| M_l2PNm16 (R) | 2 | ACh | 3 | 0.4% | 0.3 |
| lLN2X05 (R) | 2 | ACh | 3 | 0.4% | 0.3 |
| lLN2T_b (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| lLN2F_b (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| KCg-m (R) | 2 | DA | 2 | 0.3% | 0.0 |
| v2LN41 (L) | 2 | unc | 2 | 0.3% | 0.0 |
| KCa'b'-ap1 (R) | 2 | DA | 2 | 0.3% | 0.0 |
| OA-VUMa2 (M) | 2 | OA | 2 | 0.3% | 0.0 |
| OA-ASM3 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| v2LN39a (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| VP5+Z_adPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| vLN24 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| VL2p_vPN (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| DP1l_vPN (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| l2LN22 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| lLN2P_b (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe23 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL104 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| VP5+VP3_l2PN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP3+_l2PN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns VP3+_vPN | % Out | CV |
|---|---|---|---|---|---|
| KCa'b'-ap1 (R) | 14 | DA | 195 | 24.4% | 0.7 |
| DN1a (R) | 2 | Glu | 125 | 15.6% | 0.0 |
| KCg-s2 (R) | 1 | DA | 88 | 11.0% | 0.0 |
| SLP184 (R) | 1 | ACh | 80 | 10.0% | 0.0 |
| LHAV3q1 (R) | 1 | ACh | 63 | 7.9% | 0.0 |
| LHPV4c3 (R) | 2 | Glu | 61 | 7.6% | 0.1 |
| VP2+_adPN (R) | 1 | ACh | 43 | 5.4% | 0.0 |
| SMP421 (R) | 1 | ACh | 42 | 5.2% | 0.0 |
| aMe23 (R) | 1 | Glu | 39 | 4.9% | 0.0 |
| LHPD5a1 (R) | 1 | Glu | 19 | 2.4% | 0.0 |
| LHPV4c1_a (R) | 1 | Glu | 16 | 2.0% | 0.0 |
| LHPV4c1_b (R) | 1 | Glu | 7 | 0.9% | 0.0 |
| SLP210 (R) | 1 | ACh | 7 | 0.9% | 0.0 |
| VP4_vPN (R) | 1 | GABA | 3 | 0.4% | 0.0 |
| VM4_adPN (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| AVLP446 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| KCg-m (R) | 2 | DA | 2 | 0.2% | 0.0 |
| VM6_adPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6f1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| lLN1_bc (R) | 1 | ACh | 1 | 0.1% | 0.0 |
